Log in or Sign up for Free to view tailored content for your specialty!
Osteoarthritis and Bone Disorders News
Nonsurgical treatments expand knee OA care options
Knee osteoarthritis accounts for about 80% of the burden of OA worldwide, and published studies show it contributes more than $27 billion in health care costs annually.
Shared decision-making, clinical judgment take priority where OA guidelines diverge
Shared decision-making and clinical judgment are key to effectively managing osteoarthritis patients, especially when sets of osteoarthritis guidelines disagree on the best course of action, noted a speaker at the ACR State-of-the-Art Clinical Symposium.
Log in or Sign up for Free to view tailored content for your specialty!
Machine learning models may predict survival of TKR in patients with OA
Published results showed it is possible to predict when patients with knee osteoarthritis may undergo a total knee replacement and which patients would likely experience fast progression toward TKR.
USPSTF lacks evidence to recommend vitamin D deficiency screening in asymptomatic adults
The U.S. Preventive Services Task Force said there is not enough evidence to assess the balance of benefits and harms of vitamin D deficiency screening in nonpregnant, asymptomatic adults.
Beta-blockers may reduce risk for knee osteoarthritis, hip/knee pain
Common beta-blockers are associated with a reduced cumulative risk for knee osteoarthritis, knee pain and hip pain consultations, according to data published in Rheumatology.
Sprifermin may confer greater benefit to patients at risk for rapid knee OA progression
Sprifermin improved cartilage thickness and pain symptoms in a subgroup of patients with knee osteoarthritis who demonstrated low minimum joint-space width and moderate-to-high pain at baseline, according to data.
Lifestyle app lowers costs, sets goals for patients with hip, knee OA
A standalone, healthy lifestyle app, called dr. Bart, can lower costs, compared with usual care, and help provide education and goal setting for patients with osteoarthritis, according to data published in Arthritis Care & Research.
FDA panel rejects Pfizer's tanezumab for osteoarthritis pain over risk-benefit doubts
A pair of FDA advisory committees has rejected a risk mitigation proposal from Pfizer for its NGF-blocker tanezumab, stating it would fail to ensure the drug’s benefits outweigh its risks for patients with osteoarthritis.
Genicular artery embolization 'highly effective' in reducing knee OA pain
Genicular artery embolization is safe and “highly effective” in reducing symptoms of moderate-to-severe knee osteoarthritis in patients who have been unresponsive to other conservative therapy, according to data.
Older adults with hip osteoarthritis and chronic low back pain may be at risk of falls
According to researchers at the University of Delaware, older adults with concurrent hip osteoarthritis and chronic low back pain may be a high-risk group for accidental falls.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read